Combination therapy for cancer treatment
US12220420B2 · kind B2 · utility
0Cited by
49References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 2017 |
| Grant date | Feb 11, 2025 |
| Priority date | — |
| Expiry date | May 3, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating cancer in a subject includes administering at least one active agent including one or more of a thioredoxin reductase inhibitor and a glutathione depleting agent, and administering a pentaaza macrocyclic ring complex corresponding to formula (I) below:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.